Chronic illness with complexity: implications for performance measurement of optimal glycemic control
about
Looking Under the Streetlight? A Framework for Differentiating Performance Measures by Level of Care in a Value-Based Payment EnvironmentDiabetes care in black and white veterans in the southeastern U.S.The unintended consequence of diabetes mellitus pay-for-performance (P4P) program in Taiwan: are patients with more comorbidities or more severe conditions likely to be excluded from the P4P program?Comorbidity and glycemia control among patients with type 2 diabetes in primary careEstablishing chronic condition concordance and discordance with diabetes: a Delphi study.Increased cardiovascular disease, resource use, and costs before the clinical diagnosis of diabetes in veterans in the southeastern U.S.Cost-Effectiveness of a Diabetes Pay-For-Performance Program in Diabetes Patients with Multiple Chronic Conditions.Does diabetes care differ by type of chronic comorbidity?: An evaluation of the Piette and Kerr frameworkDiabetes care among elderly medicare beneficiaries with Parkinson's disease and diabetesChronic Condition Clusters and Polypharmacy among Adults.Chronic illness and patient satisfaction.Depression Treatment in Individuals with Cancer: A Comparative Analysis with Cardio-Metabolic ConditionsClinical complexity and mortality in middle-aged and older adults with diabetes.Depression and risk of hospitalizations for ambulatory care-sensitive conditions in patients with diabetes.Patients with multiple chronic conditions do not receive lower quality of preventive carePrevalence of comorbidity in primary care patients with type 2 diabetes and its association with elevated HbA1c: A cross-sectional study in Croatia.Patient complexity in quality comparisons for glycemic control: an observational study.Retrospective analysis of diabetes care in California Medicaid patients with mental illness.Therapeutic inertia and intensified treatment in diabetes mellitus prescription patterns: A nationwide population-based study in Taiwan.A diabetes pay-for-performance program and the competing causes of death among cancer survivors with type 2 diabetes in Taiwan.Does pay-for-performance benefit patients with multiple chronic conditions? Evidence from a universal coverage health care system.A Diabetes Pay-for-Performance Program and Risks of Cancer Incidence and Death in Patients With Type 2 Diabetes in TaiwanDepression and chronic illness: Asian/Pacific Islander adults in Hawaii.Risk of hypoglycemia in older veterans with dementia and cognitive impairment: implications for practice and policy.The relationship of regional hemoglobin A1c testing and amputation rate among patients with diabetes.Exploring and comparing the characteristics of nonlatent and latent composite scores: implications for pay-for-performance incentive design.The association between adherence to oral anti-diabetic drugs and hypoglycaemia in persons with Type 2 diabetes.Multidisciplinary Collaboration in the Treatment of Patients With Type 2 Diabetes in Primary Care: Analysis Using Process Mining.Pay for performance program reduces treatment needed diabetic retinopathy - a nationwide matched cohort study in Taiwan
P2860
Q30491255-68D7A59F-98C3-482C-8704-CF4F28913680Q33804752-34FE9F86-1329-4D92-B6B0-A618FF651E67Q34554665-52E1C731-68D5-4E14-9D47-692036718CF7Q34642537-77E7928F-1F65-4F98-A92C-6328DE661580Q35343158-A9912178-DADE-4D86-858E-38C36D0132CFQ35638188-D36FE428-F8FA-448B-A4EB-B65701E8636BQ35691026-ADABAE15-EC95-45BD-9B10-0E99A589A5F1Q35976407-ECF54942-55E7-4933-A9AA-5ED0A09CBCC5Q36120727-CEFAA787-D5FC-458B-9C65-1E5482E17BB7Q36151807-63143156-242F-4697-8D29-5E67C24DE460Q36469863-EED2E0BC-FD70-41AD-8A3C-5F0137AF0CB6Q36622795-641183AF-63B0-4F02-922F-55169CB92033Q36895130-D704E115-39FB-4B1D-BFC9-DA5DFAB50B7EQ36927378-187AA558-E533-4E85-A8C8-5BCDC7D79607Q37000382-0CDE0A8F-1A7A-4C9E-9ADD-7E0A906628AEQ37013537-C2E7A9C3-CA6A-4C83-9EC2-5D805570481BQ37076767-63DB570A-30E3-4AEB-8BEC-22BAA216D6A8Q37225223-D01C4E07-3A3A-4AB8-B55B-B2B27AF5FF09Q38891649-8B1A4749-8B09-4921-AF39-B5B7B11F45AFQ40190963-93C7FC86-31F2-4526-9820-A5D68AD393A1Q40972462-00CE977E-E73D-40B8-A4A6-3E0F90F2B2FEQ42684852-595C8ED4-194A-4B41-9695-F368CEB0D264Q44140075-DAE54702-30F8-411A-BA2A-1A557D3F6B83Q45330354-9AB8C16D-0930-4932-8077-9681B8BF21C6Q48054875-55078659-0B73-4FB6-89DD-126A6C06F98BQ50116285-23356B01-797B-4B02-ADC7-33ACF693DBADQ51230707-A5084D6C-BF7D-4328-80BC-4D158195FA2BQ55365194-A240E96D-F3AD-4A10-B280-C2FD2AD956D0Q58778173-3D96C89A-1400-46AB-B269-633389AD46E4
P2860
Chronic illness with complexity: implications for performance measurement of optimal glycemic control
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Chronic illness with complexit ...... nt of optimal glycemic control
@ast
Chronic illness with complexit ...... nt of optimal glycemic control
@en
type
label
Chronic illness with complexit ...... nt of optimal glycemic control
@ast
Chronic illness with complexit ...... nt of optimal glycemic control
@en
prefLabel
Chronic illness with complexit ...... nt of optimal glycemic control
@ast
Chronic illness with complexit ...... nt of optimal glycemic control
@en
P2093
P2860
P1476
Chronic illness with complexit ...... nt of optimal glycemic control
@en
P2093
Chin-Lin Tseng
Drew Helmer
Leonard Pogach
Mangala Rajan
Pramod Meduru
Usha Sambamoorthi
P2860
P2888
P304
P356
10.1007/S11606-007-0310-5
P478
22 Suppl 3
P577
2007-12-01T00:00:00Z